These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1967929

  • 1. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
    Heintz NH, Leslie KO, Rogers LA, Howard PL.
    Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929
    [Abstract] [Full Text] [Related]

  • 2. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC, Dietrich KD, Danyluk J, Paterson AH, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA.
    Cancer Res; 1991 Jan 15; 51(2):556-67. PubMed ID: 1670762
    [Abstract] [Full Text] [Related]

  • 3. [Incidence of amplification of the C-erb B2/Her-2/neu gene in human breast cancer].
    Sellami M, Gamoudi M, Krichen K, Kharrat A, Ben Romdhane K, Maalej M.
    Arch Inst Pasteur Tunis; 1991 Jan 15; 68(1-2):33-41. PubMed ID: 1687309
    [Abstract] [Full Text] [Related]

  • 4. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
    van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R.
    N Engl J Med; 1988 Nov 10; 319(19):1239-45. PubMed ID: 2903446
    [Abstract] [Full Text] [Related]

  • 5. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ, Aaltomaa S, Syrjänen S, Syrjänen K.
    Anticancer Res; 1993 Nov 10; 13(4):1147-52. PubMed ID: 8102517
    [Abstract] [Full Text] [Related]

  • 6. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 7. Her-2/neu gene amplification in ductal carcinoma in situ of the breast.
    Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM.
    Cancer Epidemiol Biomarkers Prev; 2002 Jun 15; 11(6):587-90. PubMed ID: 12050101
    [Abstract] [Full Text] [Related]

  • 8. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec 15; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 9. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
    Champème MH, Bièche I, Hacène K, Lidereau R.
    Mod Pathol; 1994 Dec 15; 7(9):900-5. PubMed ID: 7892157
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
    Bhargava R, Naeem R, Marconi S, Luszcz J, Garb J, Gasparini R, Otis CN.
    Hum Pathol; 2001 Dec 15; 32(12):1344-50. PubMed ID: 11774167
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
    Tervahauta A, Eskelinen M, Syrjänen S, Lipponen P, Pajarinen P, Syrjänen K.
    Anticancer Res; 1991 Dec 15; 11(5):1677-81. PubMed ID: 1685075
    [Abstract] [Full Text] [Related]

  • 12. HER-2/neu amplification predicts poor survival in node-positive breast cancer.
    Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL.
    Cancer Res; 1990 Jul 15; 50(14):4332-7. PubMed ID: 1973070
    [Abstract] [Full Text] [Related]

  • 13. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.
    Bacus SS, Bacus JW, Slamon DJ, Press MF.
    Arch Pathol Lab Med; 1990 Feb 15; 114(2):164-9. PubMed ID: 1967930
    [Abstract] [Full Text] [Related]

  • 14. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
    Cancer; 2003 Mar 15; 97(6):1573-81. PubMed ID: 12627523
    [Abstract] [Full Text] [Related]

  • 15. c-erbB-2 amplification in node-negative human breast cancer.
    Ro JS, el-Naggar A, Ro JY, Blick M, Frye D, Fraschini G, Fritsche H, Hortobagyi G.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6941-4. PubMed ID: 2573424
    [Abstract] [Full Text] [Related]

  • 16. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG.
    Cancer; 2003 Mar 15; 97(6):1393-403. PubMed ID: 12627502
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the cellular centrosome in fine-needle aspirations of the breast.
    Guo HQ, Gao M, Ma J, Xiao T, Zhao LL, Gao Y, Pan QJ.
    Breast Cancer Res; 2007 Mar 15; 9(4):R48. PubMed ID: 17662154
    [Abstract] [Full Text] [Related]

  • 18. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.
    Breast J; 2005 Mar 15; 11(4):278-80. PubMed ID: 15982396
    [Abstract] [Full Text] [Related]

  • 19. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y, Booser DJ, Sneige N.
    Cancer; 2005 May 01; 103(9):1763-9. PubMed ID: 15786420
    [Abstract] [Full Text] [Related]

  • 20. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis.
    Tamura G, Maesawa C, Mikawa S, Satodate R.
    Jpn J Clin Oncol; 1991 Aug 01; 21(4):264-7. PubMed ID: 1682519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.